+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Stimulation of Respiratory Motor Output and Ventilation in a Murine Model of Pompe Disease by Ampakines



Stimulation of Respiratory Motor Output and Ventilation in a Murine Model of Pompe Disease by Ampakines



American Journal of Respiratory Cell and Molecular Biology 53(3): 326-335



Pompe disease results from a mutation in the acid α-glucosidase gene leading to lysosomal glycogen accumulation. Respiratory insufficiency is common, and the current U.S. Food and Drug Administration-approved treatment, enzyme replacement, has limited effectiveness. Ampakines are drugs that enhance α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor responses and can increase respiratory motor drive. Recent work indicates that respiratory motor drive can be blunted in Pompe disease, and thus pharmacologic stimulation of breathing may be beneficial. Using a murine Pompe model with the most severe clinical genotype (the Gaa(-/-) mouse), our primary objective was to test the hypothesis that ampakines can stimulate respiratory motor output and increase ventilation. Our second objective was to confirm that neuropathology was present in Pompe mouse medullary respiratory control neurons. The impact of ampakine CX717 on breathing was determined via phrenic and hypoglossal nerve recordings in anesthetized mice and whole-body plethysmography in unanesthetized mice. The medulla was examined using standard histological methods coupled with immunochemical markers of respiratory control neurons. Ampakine CX717 robustly increased phrenic and hypoglossal inspiratory bursting and reduced respiratory cycle variability in anesthetized Pompe mice, and it increased inspiratory tidal volume in unanesthetized Pompe mice. CX717 did not significantly alter these variables in wild-type mice. Medullary respiratory neurons showed extensive histopathology in Pompe mice. Ampakines stimulate respiratory neuromotor output and ventilation in Pompe mice, and therefore they have potential as an adjunctive therapy in Pompe disease.

(PDF emailed within 0-6 h: $19.90)

Accession: 058905872

Download citation: RISBibTeXText

PMID: 25569118

DOI: 10.1165/rcmb.2014-0374OC


Related references

Reveglucosidase alfa (BMN 701), an IGF 2 Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe Disease. Journal of Pharmacology and Experimental Therapeutics (): -, 2016

Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology 64(8): 1465-1467, 2005

Generation of induced pluripotent stem (iPS) cells derived from a murine model of Pompe disease and differentiation of Pompe-iPS cells into skeletal muscle cells. Molecular Genetics and Metabolism 104(1-2): 123-128, 2012

Motor Function and Respiratory Capacity in Patients with Late-Onset Pompe Disease. Journal of Neuromuscular Diseases 2(S1): S21-S21, 2015

Non-chemical inhibition of respiratory motor output during mechanical ventilation in sleeping humans. Journal of Physiology (Cambridge) 518(2): 605-618, July 15, 1999

Ventilation and respiratory motor output during cholinergic evocation of rem sleep atonia in decerebrate cats. American Review of Respiratory Disease 145(4 PART 2): A404, 1992

Spontaneous ventilation and respiratory motor output during carbachol-induced atonia of REM sleep in the decerebrate cat. Sleep 15(5): 404-414, 1992

Controlled versus assisted mechanical ventilation effects on respiratory motor output in sleeping humans. American Journal of Respiratory and Critical Care Medicine 168(1): 92-101, 2003

Effects of chemical feedback on respiratory motor and ventilatory output during different modes of assisted mechanical ventilation. European Respiratory Journal 13(4): 873-882, 1999

Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease. Plos One 8(2): E56181-E56181, 2013

Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease. Molecular Genetics and Metabolism Reports 1(): 446-450, 2014

Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease. Human Molecular Genetics 19(4): 684-696, 2010

Stimulation of vagal C-fibers alters timing and distribution of respiratory motor output in cats. Journal of Applied Physiology 67(6): 2249-2256, 1989

Treatment of subcutaneous and mediastinal emphysema with cuirass ventilation in a patient with Pompe disease undergoing non-invasive positive pressure ventilation. Rinsho Shinkeigaku 50(5): 306-310, 2010

Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model. Clinical and Experimental Immunology 152(1): 138-146, 2008